FDA Approves First Drug for Cold Agglutinin Disease

Sutimlimab-jome is the first drug to have FDA approval for the treatment cold agglutinin disease, a rare autoimmune hemolytic anemia in which antibodies destroy red blood cells.
FDA Approvals

source https://www.medscape.com/viewarticle/967966?src=rss